Avance 临床赞助商在 2022 年 Informa Pharma Intelligence Awards 中获得年度生物技术公司奖
Aug 30, 2022 06:00 HKT |  |
|
Avance 臨床贊助商在 2022 年 Informa Pharma Intelligence Awards 中獲得年度生物技術公司獎
Aug 30, 2022 06:00 HKT | |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT | |
|
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
Aug 15, 2022 16:50 HKT |  |
|
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Aug 09, 2022 20:30 HKT |  |
|
노보텍의 유연 근무 정책, 최고 유연 근무 프로그램의 ‘2022년 우수상’ 최종 후보로 선정
Jul 26, 2022 20:00 HKT |  |
|
冠科美博 (Apollomics Inc.) 扩充其领导团队，任命 Jane Wang 博士担任首席科学官一职
Jul 26, 2022 09:19 HKT |  |
|
冠科美博 (Apollomics Inc.) 擴充其領導團隊，任命 Jane Wang 博士擔任首席科學官一職
Jul 26, 2022 09:18 HKT | |
|
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
Jul 26, 2022 09:17 HKT | |
|
Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖”
Jul 25, 2022 21:00 HKT | |
|
Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎”
Jul 25, 2022 21:00 HKT | |
|
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"
Jul 25, 2022 09:00 HKT | |
|
TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally
Jul 20, 2022 09:00 HKT |  |
|
노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표
Jul 19, 2022 18:00 HKT | |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years
Jul 19, 2022 11:00 HKT |  |
|
Novotech和Endpoints展示“中国细胞和基因治疗的演变：通用CAR-T的案例”
Jul 19, 2022 07:00 HKT | |
|
Novotech和Endpoints展示“中國細胞和基因治療的演變：通用CAR-T的案例”
Jul 19, 2022 07:00 HKT | |
|
Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T"
Jul 18, 2022 16:00 HKT | |
|
TrialWire Technology Platform Announces Success-based Patient Recruitment Plan
Jul 18, 2022 15:00 HKT | |
|
TrialWire(TM) 技术平台宣布基于成功的患者招募计划
Jul 18, 2022 15:00 HKT | |
|